๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT07050459Locally Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
220
Beijing, Haerbin, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Chengdu
2025-05-20
Recruiting
A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects
NCT07001436Renal Insufficiency
Henan Genuine Biotech Co., Ltd.
Phase 1
40
Beijing
2025-05-20
Not yet open
AI-based Prediction Model of Difficult Tracheal Intubation Using Medical Image Parameters
NCT06982144Difficult Airway
Mu Dong Liang
Observational
228
Beijing
2025-05-20
Recruiting
Use of Nasal Pressure to Assess Inspiratory Effort Under Different Oxygen Treatments
NCT06970990Critical Care, Inspiratory Effort
Jian-Xin Zhou
Not applicable
26
Beijing
2025-05-20
Not yet open
Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia
NCT06971913SLE (Systemic Lupus), CMV
Peking University People's Hospital
Phase 2
100
Beijing
2025-05-20
Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370Heart Failure
Boehringer Ingelheim
Phase 3
4,200
Beijing, Changchun, Changde, Changsha, Chengdu, Chenzhou, Chongqing, Dalian
2025-05-20
Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581Asthma
Pfizer
Phase 2
252
Beijing, Guangzhou, Baotou, Hohhot, Najing, Nanjing, Xuzhou, Nanchang
2025-05-20
Recruiting
Perioperative Treatment of Hepatoid Adenocarcinoma of Stomach
NCT06992362Hepatoid Adenocarcinoma of Stomach
Peking University Cancer Hospital & Institute
Phase 2
30
Beijing
2025-05-20
Active, closed
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
NCT06972472Obesity, Overweight, Type 2 Diabetes
Eli Lilly and Company
Phase 3
600
Beijing, Chengdu, Chongqing, Guangzhou, Harbin, Hefei, Jinan, Luoyang Shi
2025-05-19
Recruiting
To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects
NCT07013773Healthy Male and Female Subjects
Beijing Tiantan Hospital
Phase 1
20
Beijing
2025-05-19
Recruiting
Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus
NCT06881290Lupus Erythematosus, Systemic
Chinese SLE Treatment And Research Group
Phase 1
20
Beijing
2025-05-19
Recruiting
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
NCT06978647Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Inflammatory Myopathy, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
12
Beijing
2025-05-19
Not yet open
Acupuncture for Anxiety and Depression
NCT06994351Anxiety and Depression, Breast Cancer Survivor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
20
Beijing
2025-05-18
Recruiting
PBC Long-term Outcomes Study
NCT07149675Primary Biliary Cholangitis (PBC), Long-term Outcomes, Prognosis, Multicenter Prospective Study
Beijing Friendship Hospital
Observational
4,000
Beijing
2025-05-18
Recruiting
A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma
NCT07063888Intrahepatic Cholangiocarcinoma (Icc), Adjuvant Chemoradiotherapy, Narrow Margin, Lymph Node Involvement
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
66
Beijing
2025-05-16
Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
NCT06947993Atopic Dermatitis
Novartis Pharmaceuticals
Phase 2
224
Guangzhou, Shantou, Changsha, Changchun, Hangzhou, Beijing, Shanghai
2025-05-16
Not yet open
AI-driven Automated Biomedical Research
NCT06962423Biomedical Research, Artificial Intelligence (AI)
Tsinghua University
Not applicable
40
Beijing
2025-05-15
Recruiting
A Study on the Efficacy and Safety of Golidocitinib Combined With Tislelizumab and Chemotherapy as First-line Treatment for Advanced NSCLC
NCT06969612NSCLC (Advanced Non-small Cell Lung Cancer)
Peking University Cancer Hospital & Institute
Phase 1
21
Beijing
2025-05-15
Not yet open
Evaluation of AI-Generated Clinical Advice by Physicians
NCT06980467Artificial Intelligence (AI)
Tsinghua University
Not applicable
8
Beijing, Wuxi
2025-05-15
Active, closed
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
NCT06993792Obesity, Overweight, Type 2 Diabetes
Eli Lilly and Company
Phase 3
1,400
Beijing, Chengdu, Chongqing, Guangzhou, Harbin, Hefei, Jinan, Luoyang Shi
2025-05-15
Recruiting
Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU
NCT07391618Advanced Colorectal Cancer
Chinese PLA General Hospital
Phase 2
583
Beijing
2025-05-15
Not yet open
SONICURE๏ผˆSONICracker for the Treatment of UndeRExpansion๏ผ‰
NCT06924736Coronary Artery Disease
Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
Not applicable
200
Beijing
2025-05-15
Recruiting
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
NCT06990867Acute Ischemic Stroke
Corxel Pharmaceuticals
Phase 2/3
740
Baotou, Beijing, Changchun, Guangzhou, Harbin, Kaili, Linfen, Nanyang
2025-05-15
Active, closed
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
NCT06972459Obesity, Overweight
Eli Lilly and Company
Phase 3
800
Beijing, Chengdu, Chongqing, Guangzhou, Harbin, Hefei, Jinan, Luoyang Shi
2025-05-15
Recruiting
Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.
NCT07489989Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Daihong Liu
Phase 2
30
Beijing
2025-05-15
Not yet open
A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06944496Gastric Carcinoma
RemeGen Co., Ltd.
Phase 3
616
Beijing
2025-05-15
Not yet open
Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)
NCT06967363Chronic Low Back Pain (CLBP), Acute Low Back Pain, Low Back Pain, Chronic Pain
Peking University Third Hospital
Observational
360
Beijing
2025-05-15
Recruiting
Drug- Eluting Stent for Symptomatic Intracranial Arterial Stenosis
NCT07197970Symptomatic Intracranial Atherosclerotic Stenosis
Beijing Tiantan Hospital
Phase 3
224
Beijing
2025-05-15
Recruiting
A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors
NCT06926283Prostate Cancer, Other Solid Tumors, Ewing Sarcoma
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
110
Changsha, Hangzhou, Beijing
2025-05-15
Active, closed
The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer
NCT06824259Prostate Cancer
Peking University First Hospital
Not applicable
400
Beijing
2025-05-14
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT06925737Prostate Cancer, Prostatic Neoplasms
Merck Sharp & Dohme LLC
Phase 3
1,440
Beijing, Chongqing, Fuzhou, Guangzhou, Zhuhai, Nanning, Zhengzhou, Wuhan
2025-05-13
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation and Quality of Recovery After Major Noncardiac Surgery
NCT06957912Vagus Nerve Stimulation, Transcutaneous Electric Nerve Stimulation, Noncardiac Surgery, Quality of Recovery
Peking University First Hospital
Not applicable
320
Beijing
2025-05-13
Recruiting
TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer
NCT06589830Colorectal Cancer Metastatic, Advanced Colorectal Cancer
Suzhou Teligene Ltd.
Phase 2
80
Beijing
2025-05-13
Recruiting
Prospective Trial of IVL for Calcified Carotid Lesions(CREATE Trial)
NCT06936176Carotid Artery Stenosis
Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
Not applicable
204
Beijing
2025-05-12
Recruiting
A Study of ZL-1310 in Participants With Selected Solid Tumors
NCT06885281Solid Tumors
Zai Lab (Shanghai) Co., Ltd.
Phase 1/2
166
Beijing, Xiamen, Guangzhou, Harbin, Changsha, Changchun, Shanghai
2025-05-12
Recruiting
Prospective Trial of IVL for Calcified Carotid Lesions(CREATE Trial)(Extended Follow-Up)
NCT06936189Carotid Artery Stenosis
Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
Observational
204
Beijing
2025-05-12
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819891Moderately to Severely Active Crohns Disease
Hoffmann-La Roche
Phase 3
425
Ganzhou, Kunming, Jinhua, Beijing, Chengdu, Guangzhou, Haikou, Huizhou
2025-05-12
Recruiting
A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)
NCT06929299Primary Immune Thrombocytopenia (ITP)
Jiangsu BioJeTay Biotechnology Co., Ltd.
Phase 1/2
56
Bengbu, Beijing, Tangshan, Zhengzhou, Nanchang, Xiโ€™an, Tianjin
2025-05-12
Recruiting
Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer
NCT07353684Adebrelimab, Adenocarcinoma of GE Junction, Adenocarcinoma of Stomach
Beijing Friendship Hospital
Phase 2
49
Beijing
2025-05-11
Active, closed
Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects
NCT07054034Bronchial Asthma
Shanghai Mabgeek Biotech.Co.Ltd
Phase 2
160
Beijing
2025-05-11
Recruiting
Population PK-guided ATG Dosing in Haplo-HSCT
NCT07791576Hematopoietic Stem Cell Transplantation
Chinese PLA General Hospital
Phase 2
63
Beijing
2025-05-10
Recruiting
A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD
NCT07104058IgG4-Related Diseases
Luo Yaping
Not applicable
46
Beijing
2025-05-10
Recruiting
A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation
NCT06676085ECMO
Beijing Chao Yang Hospital
Not applicable
140
Beijing
2025-05-10
Not yet open
Evaluation of the Safety and Efficacy of Artificial Bone Repair Materials for Repair of Long Bone Defects in the Extremities
NCT06959459Bone Defects of the Limbs
Chinese PLA General Hospital
Not applicable
156
Beijing
2025-05-10
Recruiting
Research on the Application of 99mTc-TCR-FAPI SPECT Imaging in Rheumatoid Arthritis
NCT07138729Rheumatoid Arthritis (RA)
Luo Yaping
Not applicable
20
Beijing
2025-05-10
Recruiting
Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
NCT07138716Medullary Thyroid Carcinoma
Luo Yaping
Not applicable
30
Beijing
2025-05-10
Recruiting
Prospective Cohort Study on Fuzheng Yangxin Prescription For Rapid Rehabilitation of Patients With Qi-Yin Deficiency Syndrome After Coronary Artery Bypass Grafting
NCT06961136Coronary Artery Bypass
Peking University Third Hospital
Observational
300
Beijing
2025-05-10
Not yet open
NW-301 TCR-T in Patients With Advanced Solid Tumor
NCT06956261Tumor, Solid
Peking University
Phase 1
44
Beijing
2025-05-10
Recruiting
ICP-332 in Subjects With Non-segmental Vitiligo
NCT07047612Non Segmental Vitiligo
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2/3
603
Wuhu, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Luoyang, Nanyang
2025-05-09
Active, closed
A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease ๏ผˆMAFLD๏ผ‰
NCT06884293Overweight, Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
479
Beijing
2025-05-09
Recruiting
To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)
NCT07291921Lung Neoplasms, Neoadjuvant Therapy, Immunotherapy, Minimal Residual Disease
Peking University People's Hospital
Observational
100
Beijing
2025-05-08
Not yet open
A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects
NCT06974487Type 2 Diabetes
Gan & Lee Pharmaceuticals.
Phase 1
30
Beijing
2025-05-08
By invitation
Preliminary Effect of a Health Information Literacy Enhancement Program for Individuals With Metabolic Syndrome
NCT07051733Metabolic Syndrome (MetS)
Meihua Ji
Not applicable
30
Beijing
2025-05-08
Recruiting
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06935357Immunoglobulin A Nephropathy (IgAN)
Biogen
Phase 3
454
Fuyang, Hefei, Beijing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Shenzhen
2025-05-08
Recruiting
A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902 in Healthy Subjects
NCT06948799Oligozoospermia
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Phase 1
64
Beijing
2025-05-08
Active, closed
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer
NCT06799286Small Cell Lung Carcinoma
Bristol-Myers Squibb
Phase 1
10
Beijing, Jinan, Linyi, Hangzhou, Shanghai
2025-05-07
Recruiting
Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases
NCT07472738Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Chronic Airway Diseases
Beijing Chao Yang Hospital
Observational
950
Beijing
2025-05-07
Recruiting
Alzheimer's Disease Treated With Vagus Nerve Stimulation
NCT06923007Alzheimer Disease (AD)
Beijing Municipal Administration of Hospitals
Not applicable
74
Beijing
2025-05-07
Recruiting
Evaluation Criteria, Diagnostic Criteria, Surgical Indications, and Establishment of Surgical Standards for "Cerebral Tinnitus Syndrome" Caused by Internal Jugular Vein Stenosis.
NCT07560280Jugular Vein Anomaly (Disorder), Diagnostic Self Evaluation, Nerosurgery, Assessment, Self
Beijing Shijitan Hospital, Capital Medical University
Not applicable
369
Beijing
2025-05-07
Recruiting
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
NCT06921785Hepatocellular Carcinoma
AstraZeneca
Phase 3
1,220
Beijing, Changchun, Changsha, Chengdu, Chifeng, Chongqing, Deyang, Fuzhou
2025-05-06
Recruiting
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
NCT06952699Narcolepsy Type 2
Takeda
Phase 2
88
Beijing, Guangzhou, Changchun, Shanghai
2025-05-06
Recruiting
Study on Water Turnover of the Chinese Population Based on Deuterium Dilution Method
NCT07028021Water Turnover, Population Water Requirements, Deuterium Dilution
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Observational
300
Beijing
2025-05-06
Recruiting
A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours
NCT06868199Advanced Solid Tumours
LaNova Medicines Limited
Phase 1/2
87
Beijing
2025-05-06
Recruiting
Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study
NCT07640048Intrahepatic Cholangiocarcinoma (Icc)
Peking Union Medical College Hospital
Observational
90
Beijing
2025-05-04
Recruiting
Transcranial Electrical Stimulation for Treating Chronic Pain in Inflammatory Demyelinating Diseases
NCT06942611Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
Xuanwu Hospital, Beijing
Not applicable
80
Beijing
2025-05-03
Recruiting
Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
NCT06947356Hepatitis B
Guangzhou 8th People's Hospital
Not applicable
210
Guangzhou, Shenzhen, Shijiazhuang, Changsha, Wenzhou, Beijing
2025-05-03
Recruiting
Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy
NCT06895538Leukemia, MDS, Lymphoma
Peking University First Hospital
Phase 2/3
24
Beijing
2025-05-03
Recruiting
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
NCT06892548Advanced Lung Cancer
BioNTech SE
Phase 1/2
594
Hefei, Beijing, Fuzhou, Nanning, Weihui, Zhengzhou, Jingzhou, Xiangyang
2025-05-02
Recruiting
CHina Adrenal Venous saMPling InvestigatiON
NCT07252284Hyperaldosteronism, Adrenal Venous Sampling, Adrenalectomy
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
5,000
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Foshan, Guangzhou
2025-05-01
Not yet open
Pulsed Radiofrequency Combined With Platelet-Rich Plasma Applied to the Sphenopalatine Ganglion in Treating Episodic Cluster Headache
NCT06882278Cluster Headache, Pain Management, Episodic Cluster Headache
Beijing Tiantan Hospital
Observational
242
Beijing
2025-05-01
By invitation
An Explainable Neuroradiologist Artificial Intelligence Assistance System for Brain CT and MRI
NCT07167043Central Nervous System Disease, MRI, CT, AI (Artificial Intelligence)
Yaou Liu
Observational
30,000
Beijing
2025-05-01
Not yet open
The Safety and Efficacy of Median Nerve Electrical Stimulation for Improving Neurological Function Prognosis in Patients With Cardiac Arrest
NCT06696690Median Nerve, Coma, Post Cardiac Arrest Brain Injury
Tang Ziren
Not applicable
400
Beijing
2025-05-01
Not yet open
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
NCT06926647HBV, Chronic Hepatitis b
Beijing 302 Hospital
Observational
2,000
Ankang, Anyang, Beihai, Beijing, Binzhou, Changzhi, Changzhou, Chengdu
2025-05-01
Not yet open
68Ga-HSA PET/CT Imaging for Protein-losing Enteropathy
NCT06716788Cancer
Peking University Cancer Hospital & Institute
Observational
50
Beijing
2025-05-01
Not yet open
Relationship Between FGF19 Overexpression and Disease Prognosis
NCT06938451Hepatocellular Carcinoma (HCC)
Beijing Tsinghua Chang Gung Hospital
Observational
100
Beijing
2025-05-01
Not yet open
Zanubrutinib Combined With BR in the First-line Treatment of Waldenstrรถm's Macroglobulinemia
NCT06942507Waldenstrรถm's Macroglobulinemia (WM)
Peking Union Medical College Hospital
Not applicable
104
Beijing
2025-05-01
Recruiting
68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision
NCT06949215ccRCC, Complex Renal Cyst
Peking Union Medical College Hospital
Phase 2
70
Beijing
2025-05-01
Recruiting
Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration
NCT06991790TNBC
Peking University Cancer Hospital & Institute
Observational
51
Beijing
2025-05-01
Recruiting
Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia
NCT06869265Acute Myeloid Leukemia (AML), High Risk Acute Myeloid Leukemia(AML), Relapsed/Refractory Acute Myeloid Leukemia (AML)
Peking University People's Hospital
Phase 2
56
Beijing
2025-05-01
By invitation
Multigene Risk Score Combined With Ki-67 Dynamic Assessment in Stratified Neoadjuvant Endocrine Therapy Treatment With or Without CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
NCT06650748Breast Cancer, Early-stage Breast Cancer
Peking University
Phase 2
100
Beijing
2025-05-01
Recruiting
Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer
NCT06904677Colorectal Cancer (CRC), Neoadjuvant Therapy, Proteomics
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
400
Beijing
2025-05-01
Recruiting
Application of the Sentire C1000 for Ureteral Stricture Repair
NCT06983067Ureteral Stricture, Hydronephrosis
Xuesong Li
Observational
50
Beijing
2025-05-01
Not yet open
CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors
NCT06939270Solid Tumor
Chinese PLA General Hospital
Phase 1/2
30
Beijing
2025-05-01
Recruiting
Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet Rich Plasma to Treat Idiopathic Glossopharyngeal Neuralgia (GPN)
NCT06931457Glossopharyngeal Neuralgia, Pulsed Radiofrequency, Platelet Rich Plasma
Beijing Tiantan Hospital
Observational
121
Beijing
2025-05-01
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
NCT06916806Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis
AstraZeneca
Phase 1
72
Beijing, Shanghai, Wuhan, Zhengzhou
2025-05-01
Recruiting
A Prospective Cohort Study on Prognostic Factors in Patients With Cardiovascular-kidney-metabolic Syndrome
NCT07327606Patient With Cardiovascular-kidney-metabolic Syndrome
Peking University Third Hospital
Observational
4,526
Beijing
2025-05-01
By invitation
Validation on Clinical Adaptability of the Foundation Model Specific to Neuroimaging Diagnosis
NCT07471984Central Nervous System Disease, MRI, CT, AI (Artificial Intelligence)
Yaou Liu
Observational
50,000
Beijing
2025-05-01
Not yet open
PET-CT to Assess Brain Damage in Cardiac Arrest Patients
NCT06660238Cardiac Arrest, Brain Injuries
Capital Medical University
Observational
30
Beijing
2025-05-01
Active, closed
A Single-Arm, Open Phase I Clinical Study of Selinexor in Combination With Azacitidine for the Treatment of High-Risk AML/MDS Patients After Allo-HSCT
NCT07779031Acute Myeloid Leukaemia (AML), MDS (Myelodysplastic Syndrome)
Liping Dou
Phase 1/2
58
Beijing
2025-05-01
Recruiting
Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis
NCT06885619Left Ventricular Remodeling, Plasma Multi-Omics, Acute ST-segment Elevation Myocardial Infarction, Immunomics
Beijing Anzhen Hospital
Observational
1,000
Beijing
2025-05-01
Not yet open
Evaluation of the Effect of Healthy Lifestyle Intervention for Patients With Mild Cognitive Impairment
NCT06942780Mild Cognitive Impairment (MCI)
Xuanwu Hospital, Beijing
Not applicable
30
Beijing
2025-05
Not yet open
Study of Stapokibatrt in Children Subjects With Atopic Dermatitis
NCT06956196Atopic Dermatitis
Keymed Biosciences Co.Ltd
Phase 3
240
Beijing
2025-05
Recruiting
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
NCT06862869Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche
Observational
800
Zhanjiang, Guangzhou, Kaifeng, Zhengzhou, รœrรผmqi, Beijing, Changsha, Changzhou
2025-04-30
Recruiting
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
NCT06937944Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd.
Phase 3
669
Beijing, Chongqing, Guangzhou, Shijiazhuang, Changsha, Xuzhou, Shanghai, Xianyang
2025-04-30
Active, closed
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
NCT06948435Hypertension, Overweight or Obesity
Eli Lilly and Company
Phase 3
487
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Recruiting
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
NCT06900920Primary Immune Thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
199
Hefei, Wuhu, Beijing, Chongqing, Lanzhou, Guangzhou, Shenzhen, Zhanjiang
2025-04-30
Active, closed
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
NCT06952530Hypertension
Eli Lilly and Company
Phase 3
487
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Recruiting
Preoperative Sleep Intervention on Postoperative Delirium in Infants and Toddlers Undergoing Congenital Heart Surgery
NCT06861998Delirium - Postoperative, Sleep Problems, Congenital Heart Disease (CHD)
Yan Fuxia
Not applicable
452
Beijing
2025-04-30
Active, closed
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
NCT06948422Hypertension
Eli Lilly and Company
Phase 3
974
Beijing, Changchun, Changde, Chengdu, Chongqing, Jinan, Lishui, Luoyang Shi
2025-04-30
Recruiting
A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin
NCT07109700Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 2
216
Beijing
2025-04-30
Rows per page Showing 2201–2300 of 5484
Previous 21 22 23 24 25 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=23

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.